ATE100439T1 - 2-(2-hydroxy-3-phenoxypropylamino)-ethoxybenzol derivate. - Google Patents

2-(2-hydroxy-3-phenoxypropylamino)-ethoxybenzol derivate.

Info

Publication number
ATE100439T1
ATE100439T1 AT90907243T AT90907243T ATE100439T1 AT E100439 T1 ATE100439 T1 AT E100439T1 AT 90907243 T AT90907243 T AT 90907243T AT 90907243 T AT90907243 T AT 90907243T AT E100439 T1 ATE100439 T1 AT E100439T1
Authority
AT
Austria
Prior art keywords
hydroxy
phenoxypropylamino
ethoxybenzene
derivatives
10alkyl
Prior art date
Application number
AT90907243T
Other languages
English (en)
Inventor
Ralph Howe
Count David James Le
Balbir Singh Rao
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Application granted granted Critical
Publication of ATE100439T1 publication Critical patent/ATE100439T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/18Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
    • C07C235/20Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • C07D263/24Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Saccharide Compounds (AREA)
AT90907243T 1989-05-05 1990-04-30 2-(2-hydroxy-3-phenoxypropylamino)-ethoxybenzol derivate. ATE100439T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898910374A GB8910374D0 (en) 1989-05-05 1989-05-05 Chemical compounds
PCT/GB1990/000668 WO1990013535A1 (en) 1989-05-05 1990-04-30 Compounds

Publications (1)

Publication Number Publication Date
ATE100439T1 true ATE100439T1 (de) 1994-02-15

Family

ID=10656286

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90907243T ATE100439T1 (de) 1989-05-05 1990-04-30 2-(2-hydroxy-3-phenoxypropylamino)-ethoxybenzol derivate.

Country Status (25)

Country Link
EP (1) EP0426804B1 (de)
JP (1) JPH03506037A (de)
KR (1) KR920701123A (de)
CN (1) CN1047857A (de)
AT (1) ATE100439T1 (de)
AU (1) AU622027B2 (de)
BG (1) BG93509A (de)
CA (1) CA2015705A1 (de)
DD (1) DD300542A5 (de)
DE (1) DE69006178T2 (de)
DK (1) DK0426804T3 (de)
ES (1) ES2062526T3 (de)
FI (1) FI910059A7 (de)
GB (2) GB8910374D0 (de)
GR (1) GR1001610B (de)
HU (1) HUT58277A (de)
IE (1) IE63533B1 (de)
MW (1) MW4190A1 (de)
NO (1) NO910033L (de)
NZ (1) NZ233425A (de)
PL (1) PL285062A1 (de)
PT (1) PT93954A (de)
WO (1) WO1990013535A1 (de)
ZA (1) ZA903111B (de)
ZW (1) ZW6790A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9111426D0 (en) * 1991-05-28 1991-07-17 Ici Plc Chemical compounds
GB9111425D0 (en) * 1991-05-28 1991-07-17 Ici Plc Chemical compounds
US5502078A (en) * 1991-05-28 1996-03-26 Zeneca Limited Chemical compounds
NO179246C (no) * 1991-11-20 1996-09-04 Sankyo Co Aromatiske amino-alkoholderivater og mellomprodukter til fremstilling derav
GB9207964D0 (en) * 1992-04-10 1992-05-27 Ici Plc Chemical compounds
US5578638A (en) * 1993-11-05 1996-11-26 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists
US5563171A (en) * 1993-11-05 1996-10-08 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3-adrenergic agonists

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US463323A (en) * 1891-11-17 Temporary binder
GB1245148A (en) * 1968-11-18 1971-09-08 Pfizer Ltd Propanolamine derivatives
US4263323A (en) * 1976-10-07 1981-04-21 Aktiebolaget Hassle β-Receptor blocking compounds and treatment of cardiovascular disorders therewith
DE3271132D1 (en) * 1981-07-11 1986-06-19 Beecham Group Plc Secondary phenylethanol amines, processes for their preparation and their pharmaceutical application
GB8519154D0 (en) * 1985-07-30 1985-09-04 Ici Plc Aromatic ethers

Also Published As

Publication number Publication date
ZW6790A1 (en) 1991-02-27
CA2015705A1 (en) 1990-11-05
GR1001610B (el) 1994-07-29
NZ233425A (en) 1992-07-28
DE69006178T2 (de) 1994-05-05
DD300542A5 (de) 1992-06-17
NO910033D0 (no) 1991-01-04
NO910033L (no) 1991-03-04
ZA903111B (en) 1991-12-24
WO1990013535A1 (en) 1990-11-15
IE63533B1 (en) 1995-05-03
AU622027B2 (en) 1992-03-26
DE69006178D1 (de) 1994-03-03
MW4190A1 (en) 1991-03-13
GB9008867D0 (en) 1990-06-20
FI910059A0 (fi) 1991-01-04
EP0426804B1 (de) 1994-01-19
PT93954A (pt) 1991-01-08
KR920701123A (ko) 1992-08-11
FI910059A7 (fi) 1991-01-04
AU5540390A (en) 1990-11-29
JPH03506037A (ja) 1991-12-26
GR900100332A (en) 1991-10-10
HUT58277A (en) 1992-02-28
BG93509A (bg) 1993-12-24
IE901438L (en) 1990-11-05
EP0426804A1 (de) 1991-05-15
PL285062A1 (en) 1992-01-13
DK0426804T3 (da) 1994-05-30
ES2062526T3 (es) 1994-12-16
CN1047857A (zh) 1990-12-19
HU903384D0 (en) 1991-05-28
GB8910374D0 (en) 1989-06-21

Similar Documents

Publication Publication Date Title
FI913478A0 (fi) Diazinderivat.
DE69008142D1 (de) 4-Substituierten Imidazolen zur Senkung des intraokularen Druckes.
PT99134A (pt) Processo para a preparacao de derivados da piperazina
ES515081A0 (es) "procedimiento para la preparacion de derivados de 6-metilprednisolona".
ATE201671T1 (de) Chinolon und acridinon derivate zur behandlung der harninkontinenz
DE69413118D1 (de) Benzolsulfonamid-Derivate zur Behandlung der Blaseninstabilität
SE8502525L (sv) 1,3-oxazolidin-2-on-derivat och forfaranden for framstellning derav
ATE100439T1 (de) 2-(2-hydroxy-3-phenoxypropylamino)-ethoxybenzol derivate.
IT1196423B (it) Benzotiazolin-composti
FI863565A0 (fi) Foerfarande foer framstaellning av nya pyrrobenzimidazoler, pyrrolbenzoxazoler och pyrrolbenztiazoler.
SE8704979L (sv) Nya furanuronsyraderivat, forfarande for deras framstellning och deras anvendning
DE69005984D1 (de) 2-Hydroxy-3-phenoxypropylaminoverbindungen.
ATE63541T1 (de) N-phenylethylaminoalkyl-benzamide als antiarrhythmische mittel.
DK471979A (da) Estere af 1,1,2-triphenylalkenderivater
ATE183088T1 (de) Arzneimittel zur behandlung von hauterkrankungen
ES2002207A6 (es) Un metodo para producir derivados de glucosilmoranolina
DE3880304D1 (de) 2-hydroxy-3-aryloxy-propylaminderivate mit kardiovaskulaerer wirkung.
ES2041790T3 (es) Derivados de tetrahidroisoquinolina amino-substituidos y su procedimiento de obtencion.
DE60005525D1 (de) 2-aminotetraline zur behandlung von glaukom
ATE212842T1 (de) Quinoxalin-derivate zur behandlung von tinnitus
ES550817A0 (es) Procedimiento para preparar derivados de n-carboxialquil-2--oxo-3-diaril-5,6-triazinas
DE3782229D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
NO903585D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksaziner.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee